Latest From Biotech Now

Once Again Greenpeace is in the Hotseat!

Greenpeace logo

Do you remember in 2013 when a large group of angry farmers attacked and destroyed a field trial of genetically modified rice in the Philippines? It made headlines across the globe because GM rice has shown to have the potential to reduce Vitamin-A deficiencies causing blindness and death in many children living in the developing world. We later learned that these attackers weren’t all farmers but in fact were mostly Greenpeace activists. Ironic since Greenpeace’s motto is to “change attitudes and Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Bioscience Report Shows Industry Creating Jobs and Driving Innovation

TEConomy_BIO

BIO’s most recent industry-focused economic development report shows increased employment within the U.S. bioscience industry for the last four consecutive years. The report also shows impressive bioscience industry strength and resilience, with employment growth of nearly 10 percent since 2001. Among technology sectors the bioscience industry has been a leading performer over this period. Among the most impressive finding from the report is the strong track record of growth of the biosciences, particularly when compared Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , ,

Bloomberg Caught Spreading Another Inaccurate “False Alarm” About Drug Prices

Greenwood_Jim_BTN

I was deeply disturbed by Bloomberg’s inaccurate report this morning that attempted to examine drug costs. The article claims it “decodes [our industry’s]…pricing practices.” But, in reality, it does no such thing. It fails to take in the full picture of biopharmaceutical successes and failures; admits its “proof” is merely guesstimates from an organization that wasn’t involved in pricing decisions; and in some cases, it just plain gets the facts wrong. First, this article myopically Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

ICYMI: Gov. Tom Ridge, Tara O’Toole on Investing in Bioscience to Protect Against Bioterror

synthetic biology

Writing in the Pittsburgh Post-Gazette last week, Governor Tom Ridge and Tara O’Toole remind us that dangerous diseases are emerging more and more frequently, and that investment in bioscience is critical to fight these drug-resistant infections. When we cannot or fail to halt this spread, they create epidemics. This summer, the world is struggling to contain the spread of the Zika virus. Last fall, it was Ebola. Before that, it was MERS, SARS, avian flu. Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

ICER’s Methodology Needs to Take Into Account Key Stakeholder Voices

new-bio-logo

Last week, the Institute for Clinical and Economic Review (ICER) released the scoping document for their pending review of therapies that treat non-small cell lung cancer (NSCLC).[1] The scoping document itself lays out the importance of these therapies given the realities of this deadly disease:[2] Lung cancer is the leading cause of cancer death in the U.S.[3] It is predicted to kill 158,000 Americans this year.[4] NSCLC makes up about 85 percent of lung cancers,[5] Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,